Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects

NCT06345677 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

COMBINATION_PRODUCT: ViXe Xombination
COMBINATION_PRODUCT: Placebo + Sham

Sponsor

Vensica Therapeutics Ltd.

Collaborators

[object Object]